HML-2 DNA hypomethylation has been reported in melanoma cell lines,66 prostate tumors27 and ovarian tumor.15 Interestingly, age was negatively associated with HML-2 methylation in PBMCs from healthy donors aged 20–88 years. Here, CLEC10A is linked to ovarian neoplasm.